REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro de Celulas Madre y Biotecnologia S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Centro de Celulas Madre y Biotecnologia S.A.S. Profile Updated: June 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Centro de Celulas Madre y Biotecnologia S.A.S. is an enterprise based in Colombia. Its main office is in Pereira. It operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on January 30, 2014. 9 (2024) employees currently work for Centro de Celulas Madre y Biotecnologia S.A.S.. In 2023, the company reported a net sales revenue increase of 6.5%. Over the same period, its total assets grew by 82.49%.

Headquarters
Calle 14 Nro. 23-41 Sector Alamos Pereira
Pereira; Risaralda;

Contact Details: Purchase the Centro de Celulas Madre y Biotecnologia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Centro de Celulas Madre y Biotecnologia S.A.S. report to view the information.
Outstanding Shares:
Purchase the Centro de Celulas Madre y Biotecnologia S.A.S. report to view the information.
Incorporation Date:
January 30, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro de Celulas Madre y Biotecnologia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
6.5%
Total operating revenue
6.5%
Total assets
82.49%
Total equity
99.99%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?